See more : Bidstack Group Plc (BIDS.L) Income Statement Analysis – Financial Results
Complete financial analysis of Rafina Innovations Inc. (VICA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rafina Innovations Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- China Greenfresh Group Co., Ltd. (6183.HK) Income Statement Analysis – Financial Results
- Barbeque Nation Hospitality Ltd. (BARBEQUE.BO) Income Statement Analysis – Financial Results
- Suzuki Motor Corporation (SZKMF) Income Statement Analysis – Financial Results
- PharmaCom BioVet, Inc. (PHMB) Income Statement Analysis – Financial Results
- Cashbuild Limited (CBUDY) Income Statement Analysis – Financial Results
Rafina Innovations Inc. (VICA)
About Rafina Innovations Inc.
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 3.26M | 0.00 | 55.52K | 412.68K | 355.74K | 687.45K | 60.12K | 27.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 3.43M | 46.90K | 2.48K | 144.37K | 130.17K | 321.71K | 31.79K | 17.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -168.55K | -46.90K | 53.04K | 268.31K | 225.56K | 365.74K | 28.33K | 9.94K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | -5.17% | 0.00% | 95.54% | 65.02% | 63.41% | 53.20% | 47.13% | 36.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 127.27K | 278.71K | 1.29M | 340.78K | 5.32M | 2.65M | 2.74K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 4.14M | 1.72M | 1.56M | 1.92M | 465.60K | 1.34M | 13.63K | 23.40K | 35.38K | 32.34K | 152.01K | 99.15K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 699.70K | 13.78K | 1.10M | 4.14M | 1.72M | 1.56M | 1.92M | 465.60K | 1.34M | 13.63K | 23.40K | 35.38K | 32.34K | 152.01K | 99.15K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 699.70K | 13.78K | 1.23M | 4.50M | 3.11M | 1.97M | 7.29M | 3.12M | 1.34M | 13.63K | 23.40K | 35.38K | 32.34K | 152.01K | 99.15K |
| Cost & Expenses | 0.00 | 4.13M | 60.68K | 1.23M | 4.65M | 3.24M | 2.29M | 7.32M | 3.14M | 1.34M | 13.63K | 23.40K | 35.38K | 32.34K | 152.01K | 99.15K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 3.00 | 215.00 | 0.00 |
| Interest Expense | 0.00 | 10.96K | 24.30K | 19.96K | 3.59K | 6.14K | 3.98K | 379.74K | 179.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 12.11K | 46.90K | 15.00K | 81.76K | 96.40K | 67.65K | 47.56K | 6.50K | 383.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | -856.14K | -13.78K | -1.16M | -5.76M | -2.80M | -1.54M | -9.01M | -18.84M | -1.34M | -13.63K | -23.40K | -35.38K | -32.34K | -151.80K | -99.15K |
| EBITDA Ratio | 0.00% | -26.24% | 0.00% | -2,092.43% | -1,006.74% | -783.19% | -223.72% | -11,992.19% | -11,482.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | -868.25K | -60.68K | -1.18M | -4.24M | -2.88M | -1.61M | -7.26M | -3.26M | -1.34M | -13.63K | -23.40K | -35.38K | -32.34K | -152.01K | -99.15K |
| Operating Income Ratio | 0.00% | -26.61% | 0.00% | -2,119.45% | -1,026.55% | -810.29% | -233.56% | -12,071.30% | -12,060.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | -10.96K | -24.30K | -20.64K | -1.61M | -24.95K | -1.79K | -2.18M | -15.76M | -383.00 | 0.00 | 0.00 | 1.00 | 3.00 | 215.00 | 0.00 |
| Income Before Tax | 0.00 | -879.21K | -84.98K | -1.20M | -5.85M | -2.91M | -1.61M | -9.44M | -19.02M | -1.34M | -13.63K | -23.40K | -35.38K | -32.34K | -151.80K | -99.15K |
| Income Before Tax Ratio | 0.00% | -26.95% | 0.00% | -2,156.62% | -1,417.52% | -817.30% | -233.82% | -15,693.94% | -70,275.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | -2.00 | 5.00 | 3.59K | 80.00K | -11.20K | 906.00 | 179.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 0.00 | -879.21K | -84.98K | -1.20M | -5.85M | -2.99M | -1.60M | -9.44M | -19.02M | -1.34M | -13.63K | -23.40K | -35.38K | -32.34K | -151.80K | -99.15K |
| Net Income Ratio | 0.00% | -26.95% | 0.00% | -2,156.62% | -1,417.52% | -839.79% | -232.19% | -15,695.45% | -70,275.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.01 | 0.00 | -0.07 | -0.43 | -0.30 | -0.17 | -1.22 | -8.89 | -1.08 | -0.01 | -0.02 | -0.03 | -0.03 | -0.13 | -0.09 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.07 | -0.43 | -0.30 | -0.17 | -1.22 | -8.89 | -1.08 | -0.01 | -0.02 | -0.03 | -0.03 | -0.13 | -0.09 |
| Weighted Avg Shares Out | 0.00 | 79.56M | 24.88M | 16.95M | 13.75M | 9.96M | 9.61M | 7.76M | 2.14M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.20M | 1.05M |
| Weighted Avg Shares Out (Dil) | 0.00 | 79.56M | 24.88M | 16.95M | 13.75M | 9.96M | 9.61M | 7.76M | 2.14M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.20M | 1.05M |
OPTEC International Acquires Controlling Interest of Rafina Innovations
Rafina's Subsidiary C-Pharm Ltd Revenues for First Quarter 2021 $1.7 Million
Rafina Innovations Inc. Announces Brand-New Website and Exclusive Distributor Agreement with OPTEC International Inc.
Source: https://incomestatements.info
Category: Stock Reports